Literature DB >> 28413513

Huperzine A inhibits immediate addictive behavior but not behavioral sensitization following repeated morphine administration in rats.

Jinling Sun1, Lin Tian1, Ruisi Cui1, Xinwang Li1.   

Abstract

Acetylcholinesterase inhibitors are regarded as promising therapeutic agents to treat addiction. The current study aimed to examine the effects of huperzine A, a cholinesterase inhibitor, on behavioral sensitization induced by repeated morphine administration and relapse induced by contextual conditioning. The present study also assessed whether the state-dependency hypothesis may explain the results. Adult rats were divided into four groups (n=8) and intraperitoneally injected with 0.2, 0.3 or 0.4 mg/kg huperzine A or saline (1 ml/kg, control), for 5 days. The effect of repeated huperzine A administration alone on locomotor activity was assessed. For the experiments that analyzed the development of morphine-induced sensitization, 40 rats were divided into five groups (n=8): Saline+Saline, Saline+Morphine, 0.2, 0.3 and 0.4 mg/kg huperzine A+Morphine. Following a withdrawal period of 7 days, all animals were administered saline or morphine, as appropriate. To test the state-dependency hypothesis, the rats in the Saline+Morphine group were injected with saline and morphine, while the other three groups were administered different doses of huperzine A and morphine. To examine the effect of huperzine A on the expression of morphine-induced sensitization, the rats in huperzine A+Morphine groups were injected with appropriate concentrations of huperzine A, and morphine. The current results indicated that the administration of huperzine A alone did not affect locomotor activity, while higher doses of huperzine A inhibited the addictive behavior induced by morphine at the development phase. Additionally, huperzine A administration during the expression phase of morphine sensitization did not inhibit the relapse induced by administration of saline. Furthermore, 0.4 mg/kg huperzine A inhibited the expression of morphine-induced behavioral sensitization. Therefore, the results of the current study do not support the state-dependency hypothesis.

Entities:  

Keywords:  behavioral sensitization; cholinesterase inhibitor; huperzine A; morphine

Year:  2017        PMID: 28413513      PMCID: PMC5377550          DOI: 10.3892/etm.2017.4097

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  49 in total

1.  Changes in electrophysiological properties of nucleus accumbens neurons depend on the extent of behavioral sensitization to chronic methamphetamine.

Authors:  Anne Marie Brady; Stanley D Glick; Patricio O'Donnell
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 2.  Neurobiology of craving, conditioned reward and relapse.

Authors:  Friedbert Weiss
Journal:  Curr Opin Pharmacol       Date:  2005-02       Impact factor: 5.547

Review 3.  Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.

Authors:  Rui Wang; Han Yan; Xi-can Tang
Journal:  Acta Pharmacol Sin       Date:  2006-01       Impact factor: 6.150

4.  Effects of huperzine A on memory deficits and neurotrophic factors production after transient cerebral ischemia and reperfusion in mice.

Authors:  Zhi-fei Wang; Li-li Tang; Han Yan; Yu-jun Wang; Xi-can Tang
Journal:  Pharmacol Biochem Behav       Date:  2006-05-09       Impact factor: 3.533

5.  Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.

Authors:  Hai Yan Zhang; Xi Can Tang
Journal:  Trends Pharmacol Sci       Date:  2006-10-23       Impact factor: 14.819

6.  Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization.

Authors:  M Jeziorski; F J White
Journal:  Eur J Pharmacol       Date:  1995-03-14       Impact factor: 4.432

7.  Locomotor activity in a novel environment predicts both responding for a visual stimulus and self-administration of a low dose of methamphetamine in rats.

Authors:  Amy M Gancarz; Michele A San George; Lisham Ashrafioun; Jerry B Richards
Journal:  Behav Processes       Date:  2011-01-05       Impact factor: 1.777

8.  Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.

Authors:  Yan Qi Liang; Xi Can Tang
Journal:  Neurosci Lett       Date:  2004-05-06       Impact factor: 3.046

9.  Parametric analysis of the development and expression of ethanol-induced behavioral sensitization in female Swiss mice: effects of dose, injection schedule, and test context.

Authors:  Vincent Didone; Caroline Quoilin; Ezio Tirelli; Etienne Quertemont
Journal:  Psychopharmacology (Berl)       Date:  2008-08-07       Impact factor: 4.530

10.  MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation.

Authors:  W A Carlezon; A Mendrek; R A Wise
Journal:  Synapse       Date:  1995-05       Impact factor: 2.562

View more
  3 in total

1.  Restraint Stress Potentiated Morphine Sensitization: Involvement of Dopamine Receptors within the Nucleus Accumbens.

Authors:  Elham Charmchi; Golnaz Faramarzi; Mina Rashvand; Morteza Zendehdel; Abbas Haghparast
Journal:  Neurochem Res       Date:  2021-01-03       Impact factor: 3.996

Review 2.  A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis.

Authors:  Mayuri Shukla; Prapimpun Wongchitrat; Piyarat Govitrapong
Journal:  Neurochem Res       Date:  2022-02-05       Impact factor: 3.996

Review 3.  The Cholinergic System as a Treatment Target for Opioid Use Disorder.

Authors:  Kevin P Jensen; Elise E DeVito; Sarah Yip; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.